SOPHiA GENETICS SA (NASDAQ: SOPH) has announced that it will be releasing its financial results for the third quarter of 2024 on Tuesday 5th November 2024. The report will be made available before market open, allowing investors and analysts to evaluate the company's performance during this period.
Financial analysts on Wall Street are predicting that the establishment is expected to report an estimated per share $0.23 loss for the current quarter. Additionally, the company is anticipated to reveal a total revenue of $15.85 million during this period.
According to the Wall Street analysts projections, the company is expected to generate a total revenue of $65.66 million for the fiscal year. Additionally, these analysts anticipate that the company will report loss of $0.91 per share during the same period.
In the corresponding quarter of the previous year, the company's earnings report unveiled a per-share loss of $0.21. Notably, the company's total revenue reached an impressive $16.3 million during that specific period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $-0.23 | +30.3% | 15.81 M | +5.0% |
| Q1 2024 | $-0.21 | +19.2% | 15.78 M | +13.0% |
| Q4 2023 | $-0.37 | -117.6% | 17.05 M | +27.4% |
| Q3 2023 | $-0.21 | +30.0% | 16.30 M | +40.0% |
| Q2 2023 | $-0.33 | -6.5% | 15.05 M | +29.0% |
| *Growth on year-over-year basis | ||||
SOPH has scheduled a conference call on 5th November 2024 at 08:00 AM eastern time to discuss the third quarter financial results and other related information.
SOPHiA GENETICS SA (SOPH) shares traded as low as $3.60 and as high as $3.75 on a day volume of 8.30 thousand shares, closed Friday's regular trading session at $3.64, a rise of 1.68 percent.
